Latest news
Loading news…
Ceptaris Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Malvern, Pennsylvania, United States Founded 2002 11-50 employees For Profit
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
Ceptaris Therapeutics was acquired by Actelion Pharmaceuticals in 2013 for $250M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
Company Info
- Founded
- 2002
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 1
- HQ
- Malvern, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
- Exit date
- Jul 31, 2013
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- -0.8
- Trend (90d)
- -0.6
Key People at Ceptaris Therapeutics
Executive Vice President, Head of Research and Development
Co-Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ceptaris Therapeutics
Loading news…
FAQs about Ceptaris Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.